Company / Current Assets
Insulet Corporation Current Assets History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.9B
FY2025
5-year range
$1.3B / $1.9B
FY2021-FY2025
Trend
+1.2%
vs FY2024
Sector context
#55 of 165
Health Care
What the data says
At $1.9B, Insulet Corporation's current assets ranks #55 of 165 in the Health Care sector. Current Assets has increased for 3 consecutive years, from $1.3B in FY2022 to $1.9B in FY2025.
Based on SEC 10-K filings.
$1.9B in FY2025 with a 5-year CAGR of +8.9%.
Improved from $1.6B to $1.9B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +13.4%
- 5-Year CAGR
- +8.9%
- 10-Year CAGR
- -
Sector benchmark
#55 of 165 in Health CareTop 33% of 165This company $1.9B Sector average $5.2B
▼
-63.5% below sector average
Key checks
Key Insights
- Insulet Corporation's current assets has grown for 3 consecutive years.
- 5-year CAGR of +8.9%, indicating consistent growth.
- In FY2025, current assets increased 1.2% year-over-year.
- Ranks #55 out of 165 companies in the Health Care sector.
Company context
Key Data Points
- Strong profit margin: 20.2%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.9B | +1.2% |
| FY2024 | $1.9B | +19.5% |
| FY2023 | $1.6B | +20.5% |
| FY2022 | $1.3B | -1.2% |
| FY2021 | $1.3B | +6.5% |
| FY2020 | $1.2B | +111.3% |
| FY2019 | $591.0M | +28.1% |
| FY2018 | $461.3M | -14.1% |
| FY2017 | $537.2M | +45.2% |
| FY2016 | $370.0M | +93.9% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026